Elevation Oncology, Inc. (ELEV) Misses Q1 EPS by 4c
Tweet
Share
E-mailGet Alerts ELEV Hot Sheet
Join SI Premium – FREE
Elevation Oncology, Inc. (NASDAQ: ELEV) reported Q1 EPS of ($0.24), $0.04 worse than the analyst estimate of ($0.20).
For earnings history and earnings-related data on Elevation Oncology, Inc. (ELEV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
- Mosaic sets pricing for tender offers on up to $1.4B in debt
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
